NCT03187600 is a NA clinical trial of Mucosa/submucosa Pharyngeal Flap in Velopharyngeal Insufficiency, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's.

What drugs are being tested in NCT03187600?

Interventions in NCT03187600: Mucosa/submucosa Pharyngeal Flap, Standard of Care Pharyngeal Flap.

What condition does NCT03187600 study?

NCT03187600 studies Velopharyngeal Insufficiency.

Is NCT03187600 still recruiting?

NCT03187600 is currently status unknown. Last updated 25 August 2017.

Last reviewed 2017-08-25 · How we verify

NCT03187600

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Submucosa/Mucosal Pharyngeal Flap Trial

Status unknown NA Last updated 25 August 2017

What this trial tests

NA trial testing Mucosa/submucosa Pharyngeal Flap in Velopharyngeal Insufficiency in 20 participants. Status unknown.

Timeline

18 July 2017

Primary endpoint
10 June 2020

10 June 2020

Quick facts

Lead sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	18 July 2017
Primary completion	10 June 2020
Estimated completion	10 June 2020
Sites	1 location across Canada

Drugs / interventions tested

Mucosa/submucosa Pharyngeal Flap
Standard of Care Pharyngeal Flap

Conditions studied

Velopharyngeal Insufficiency — all drugs for Velopharyngeal Insufficiency →

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

Eligibility, any sex, with Velopharyngeal Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators want to compare two different surgical techniques for the treatment of a condition called velopharyngeal dysfunction (VPD). VPD is a condition in which the nasal part of the airway does not close properly during speaking and feeding. The current standard surgical management involves taking a pharyngeal flap from the back of the throat comprised of muscle and overlying mucosal tissue to create a functioning valve. The proposed technique would use only the mucosal/submucosal layer of the pharynx for the flap. This technique has been shown to be effective in animal models and it is hoped that it will lead to faster healing, lower complications and improved functional outcome for patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Velopharyngeal Insufficiency

Currently open trials in the same condition.

NCT07264036 — Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study · NA · recruiting

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

NCT07588711 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury · NA · not yet recruiting
NCT07585292 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy · NA · not yet recruiting
NCT07510906 — Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT06035809 — Sensory Motor Arousal Regulation Treatment (SMART) Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03187600 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Last refreshed: 25 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03187600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing